Medscape’s June 2025 video features JoAnn Manson discussing a substudy of the VITAL trial. The description draws attention to telomeres, structures at the ends of chromosomes, and asks what their change over time might mean.
The paper reports less shortening of white blood cell telomeres in the vitamin D3 group than in the placebo group over four years. The publisher’s description also mentions the need to repeat the finding.
Original sources
Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial
Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial.
Publication details
Vitamin D3 and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial
